These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1309478)

  • 1. Overview of adrenergic anorectic agents.
    Wellman PJ
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):193S-198S. PubMed ID: 1309478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology of the anorexic effect of phenylpropanolamine.
    Wellman PJ
    Drugs Exp Clin Res; 1990; 16(9):487-95. PubMed ID: 2100250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of systemic phenylpropanolamine and fenfluramine on serotonin activity within rat paraventricular hypothalamus.
    McMahon LR; Wellman PJ
    Physiol Behav; 1996 Jan; 59(1):63-9. PubMed ID: 8848492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of phenylpropanolamine anorexia in rats by the alpha-1 receptor antagonist benoxathian.
    Wellman PJ; Davies BT
    Pharmacol Biochem Behav; 1991 Apr; 38(4):905-8. PubMed ID: 1678528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of the involvement of paraventricular hypothalamic alpha 2-adrenoceptors in phenylpropanolamine anorexia.
    Davies BT; Wellman PJ; Morien A
    Physiol Behav; 1993 Jul; 54(1):121-8. PubMed ID: 8392206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of cirazoline- and phenylpropanolamine-induced anorexia by the alpha 1-receptor antagonist prazosin.
    Wellman PJ; Davies BT
    Pharmacol Biochem Behav; 1992 May; 42(1):97-100. PubMed ID: 1356275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of paraventricular hypothalamic microinjections of phenylpropanolamine and d-amphetamine on mash intake in rats.
    Wellman PJ; Davies BT
    Brain Res Bull; 1990 Aug; 25(2):335-8. PubMed ID: 2224544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of feeding induced by phenylephrine microinjections within the paraventricular hypothalamus in rats.
    Wellman PJ; Davies BT
    Appetite; 1991 Oct; 17(2):121-8. PubMed ID: 1837207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both alpha1-adrenergic and D(1)-dopaminergic neurotransmissions are involved in phenylpropanolamine-mediated feeding suppression in mice.
    Cheng JT; Kuo DY
    Neurosci Lett; 2003 Aug; 347(2):136-8. PubMed ID: 12873745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the alpha 1a-adrenoceptor antagonist RS-17053 on phenylpropanolamine-induced anorexia in rats.
    Wellman PJ; McMahon LR; Green T; Tole A
    Pharmacol Biochem Behav; 1997; 57(1-2):281-4. PubMed ID: 9164583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of perifornical hypothalamic microinjections of phenylpropanolamine and amphetamine on latency to feed and mash intake in rats.
    Wellman PJ; Cockroft R
    Pharmacol Biochem Behav; 1990 Feb; 35(2):461-4. PubMed ID: 2320656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of feeding by hypothalamic paraventricular nucleus alpha 1- and alpha 2-adrenergic receptors.
    Wellman PJ; Davies BT; Morien A; McMahon L
    Life Sci; 1993; 53(9):669-79. PubMed ID: 8102768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y (NPY) in phenylpropranolamine-mediated appetite suppression.
    Hsieh YS; Hsu JD; Yang SF; Kuo DY
    Peptides; 2004 Dec; 25(12):2155-61. PubMed ID: 15572205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcript of protein kinase A knock-down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    Physiol Genomics; 2007 Oct; 31(2):306-14. PubMed ID: 17684035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the role of oxytocin receptors in phenylpropanolamine-induced anorexia in rats.
    McMahon LR; Wellman PJ
    Pharmacol Biochem Behav; 1997 Aug; 57(4):767-70. PubMed ID: 9259004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site of action of anorectic drugs: glucoprivic- versus food deprivation-induced feeding.
    Angel I; Stivers JA; Paul SM; Crawley JN
    Pharmacol Biochem Behav; 1987 Jun; 27(2):291-7. PubMed ID: 3628443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intra-PVN injections of d- and l-norephedrine on feeding in rats.
    Wellman PJ; DiCarlo B; Morien A; Davies BT
    Brain Res Bull; 1993; 32(4):443-5. PubMed ID: 8221134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central stimulation of oxytocin release in the lactating rat: interaction of neuropeptide Y with alpha-1-adrenergic mechanisms.
    Parker SL; Crowley WR
    Endocrinology; 1993 Feb; 132(2):658-66. PubMed ID: 8381069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of adrenoceptors in the hypothalamic paraventricular nucleus in corticotropin-releasing factor-induced sympatho-adrenomedullary outflow in rats.
    Okada S; Yamaguchi N
    Auton Neurosci; 2017 Mar; 203():74-80. PubMed ID: 28202248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression.
    Hsieh YS; Yang SF; Chiou HL; Kuo DY
    Behav Neurosci; 2007 Oct; 121(5):933-40. PubMed ID: 17907825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.